Company Filing History:
Years Active: 2007-2010
Title: Arndt Godau: Innovator in Cardiac Device Technology
Introduction
Arndt Godau is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of cardiac device technology. With a total of 3 patents, he has developed innovative solutions aimed at improving heart function and patient outcomes.
Latest Patents
One of his latest patents is an "Implantable cardiac device providing intrinsic conduction encouragement and method." This device promotes intrinsic activity of the heart during demand pacing, increasing the time and probability of an AV delay interval extension. It encourages intrinsic AV conduction in patients with intact AV conduction by allowing multiple cycles during a search interval and multiple search times to further promote intrinsic conduction from the atrium to the ventricle.
Another notable patent is the "Automatic signal amplitude measurement system in the setting of abnormal rhythms." This system evaluates the sensing and detection of physiological processes by an implantable medical device. It includes an automatic testing algorithm that iteratively adjusts the threshold and gain settings of the device, refining its programming for better accuracy in detecting physiological processes.
Career Highlights
Arndt Godau has made significant strides in the medical device industry, particularly through his work at Pacesetter, Inc. His innovative designs and patents have contributed to advancements in cardiac health technology, enhancing the quality of life for patients with heart conditions.
Collaborations
Throughout his career, Arndt has collaborated with notable colleagues, including Paul A. Levine and Donald S. Cogan. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge medical devices.
Conclusion
Arndt Godau's work in the field of cardiac devices exemplifies the impact of innovation on healthcare. His patents and contributions continue to shape the future of cardiac technology, ultimately benefiting patients worldwide.